Close Menu
    What's Hot

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      AIR Asset Management’s Taylor Garvey Joins LISA Board, Promoted to Managing Director

      January 19, 2026

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Editor’s Letter – Volume 2, Issue 9, September 2023

    Magazine September 15, 2023By Chris Wells
    Editor's Letter
    Share
    Twitter LinkedIn Email

    Download Life Risk News Volume 2, Issue 9, September 2023

    The pension risk transfer market in the US is now a $50bn+ market, but unlike the UK, it’s one where private equity and private debt funds are playing increasing roles. That’s not gone unnoticed by some groups, so Aaron Woolner spoke to Charles Decker, a Researcher at UNITE HERE, and Joe Engelhard, Senior Counsel, US Policy & Regulation at the Alternative Investment Management Association to understand both the reservations that some have about this development, and the rebuttal, in Spotlight Falls on US Life Insurer’s Private Debt Investments, our cover story this month.

    Higher interest rates have had an impact on all alternative investment strategies in the past twelve months and will continue to do so as they remain elevated when compared to the post-GFC decade. Perhaps no impact, however, is greater than that of the German secondary life insurance policy market which, due to its structure, is now largely defunct. Greg Winterton spoke to Anna Bailey, a Board member at trade group BVZL, for her views on the likelihood of the market returning in The US Now The Last Remaining Traded Life Policy Market.

    The US Securities and Exchange Commission established a Life Settlement Task Force in 2009 to examine then-emerging issues in the life settlement market and advise whether market practices and regulatory oversight could be improved. Fourteen years later, the task force is yet to deliver its recommendations to Congress. Jeffrey Davis spoke to JoAnn M. Strasser, Partner and Chair, Investment Management at Thompson Hine LLP and Ron S. Geffner, Founding Partner at Sadis & Goldberg LLP, for their thoughts as to why in Re-Visiting the SEC Life Settlements Task Force More Than a Decade Later.

    Life insurance companies have a reputation for being something akin to an oil tanker – big, and slow. But their approach to incorporating generative AI (GenAI) into various functions of their businesses can hardly be claimed to be thus. A snap poll conducted by technology consulting firm, Celent, in July this year revealed that 10% of life insurers in the United States were already using GenAI in production. Greg Winterton spoke to Keith Raymond, Principal Analyst, Insurance at Celent to learn more about this trend in Generative AI Set to Transform Life Insurance Industry.

    Many investors in the life settlements asset class do not fully grasp the complexities underlying the asset before making the decision to invest in it; life settlements are more complicated to acquire and manage than other comparable discounted cash flow assets. Maurizio Pellegrini, Life ILS Manager at Azimut Investments, explains three areas that investors should pay close attention to before deploying capital in the space in The Critical Nature of Life Insurance Policy Due Diligence in the Life Settlement Asset Class, our first commentary article this month.

    The UK’s Continuous Mortality Investigation (CMI) carries out research into mortality and morbidity experience and produces practical tools that are widely used by actuaries. It published its most recent set of projections in July, showing lower life expectancies. So, for August’s poll, we asked, ‘How Significant Will the Impact of the Latest CMI Data on UK Life Expectancy Be on Life Risk Markets? ’

    The US Centers for Disease and Control (CDC) tracks all causes of death and has published provisional summary for 2022 deaths, including Covid-19 related deaths. However, the life insurance subset is generally a higher economic demographic subset with longer than average life expectancies, and John Lynch, Director of Actuarial & Underwriting Services, Longevity Holdings, takes a closer look at where Covid-19 and life settlements meet in Covid-19 Excess Mortality Analysis, our second commentary piece this month.

    The involvement of the capital markets in terms of its capability to absorb longevity risk has been talked about for years, but action has been largely absent. Greg Winterton caught up with David Blake, Professor of Finance & Director of the Pensions Institute, Bayes Business School, to get his thoughts on the current state of the longevity financing conundrum in this month’s Q&A.

    Participants in the UK equity release market – insurance companies, advisers and consultants – generally agree that the industry has something of an awareness challenge. But the current macroeconomic environment is changing that, and Greg Winterton spoke to Rudy Khaitan, Managing Partner at Senior Capital, Ben Grainger, Partner at EY, and Steve Kyle, Secretary General of European Pensions and Property Asset Release Group, to get their views on the outlook for growth in the market in Equity Release Fundamentals Underpin Growth Opportunity.

    I hope you enjoy the latest issue of Life Risk News.

    Chris Wells
    Managing Editor
    Life Risk News

    2023 - September Editor's Letter Volume 2 Issue 9 - September 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Editor’s Letter – Volume 2, Issue 1, January 2026

    January 14, 2026By Chris Wells

    Editor’s Letter – Volume 1, Issue 3, December 2025

    December 10, 2025By Chris Wells

    Editor’s Letter – Volume 1, Issue 2, November 2025

    November 12, 2025By Chris Wells

    Editor’s Letter – Volume 1, Issue 1, October 2025

    October 8, 2025By Chris Wells
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.